Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2000
Identifying breast cancer patients at high risk for bone metastases
M Colleoni, A O'Neill, A Goldhirsch, et al.
British Journal of Cancer
|
June 28, 2002
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
M Colleoni, H J Litman, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
D Crivellari, M Bonetti, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2021
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
G Jerusalem, S Farah, A Courtois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
M Untch, R D Gelber, C Jackisch, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 2, 2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer
P A Francis, O Pagani, G F Fleming, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
A S Allal, C Ares, P Dulguerov, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2000
Identifying breast cancer patients at high risk for bone metastases
M Colleoni, A O'Neill, A Goldhirsch, et al.
British Journal of Cancer
|
June 28, 2002
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
M Colleoni, H J Litman, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
D Crivellari, M Bonetti, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2021
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
G Jerusalem, S Farah, A Courtois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
M Untch, R D Gelber, C Jackisch, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 2, 2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer
P A Francis, O Pagani, G F Fleming, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
A S Allal, C Ares, P Dulguerov, et al.
Page
of 15